Corneliu Bolbocean

Corneliu Bolbocean

UNVERIFIED PROFILE

Are you Corneliu Bolbocean?   Register this Author

Register author
Corneliu Bolbocean

Corneliu Bolbocean

Publications by authors named "Corneliu Bolbocean"

Are you Corneliu Bolbocean?   Register this Author

7Publications

163Reads

29Profile Views

Economic impact of genomic diagnostics for intermediate-risk acute myeloid leukaemia.

Br J Haematol 2016 08 21;174(4):526-35. Epub 2016 Apr 21.

Canadian Centre for Applied Research in Cancer Control (ARCC), Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14076DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021117PMC
August 2016

Perinatal Regionalization and Implications for Long-Term Health Outcomes in Cerebral Palsy.

Can J Neurol Sci 2016 Mar 21;43(2):248-53. Epub 2016 Jan 21.

2Department of Pediatrics,McGill University,Montreal,Quebec.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/cjn.2015.322DOI Listing
March 2016

Resource utilization and costs during the initial years of lung cancer screening with computed tomography in Canada.

J Thorac Oncol 2014 Oct;9(10):1449-58

*The Canadian Centre for Applied Research in Cancer Control, and the British Columbia Cancer Agency, Vancouver, British Columbia, Canada; †The British Columbia Cancer Agency, Vancouver, British Columbia, Canada; ‡Brock University, St. Catherines, Ontario, Canada; §Cancer Care Ontario and the Juravinski Cancer Centre, Hamilton, Ontario, Canada; ‖University Health Network and Princess Margaret Cancer Centre, Toronto, Ontario, Canada; ¶The Canadian Centre for Applied Research in Cancer Control, the British Columbia Cancer Agency and School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada; #The University of British Columbia School of Population and Public Health, Vancouver, British Columbia, Canada; **Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada; ††The British Columbia Cancer Agency and The Canadian Centre for Applied Research in Cancer Control and the University of British Columbia, Vancouver, British Columbia, Canada; ‡‡Beatrice Hunter Cancer Research Institute and Dalhousie University, Halifax, Nova Scotia, Canada; §§The Vancouver General Hospital, Vancouver, British Columbia, Canada; ‖‖Fionna Stanley Hospital and Sir Charles Gairdner Hospital, Perth, Western Australia; ¶¶Université Laval, Québec, Canada; ##Vancouver General Hospital, The University of British Columbia, Vancouver, British Columbia, Canada; ***The Juravinski Cancer Centre and McMaster University, Hamilton, Ontario, Canada; †††Princess Margaret Cancer Centre, Toronto, Ontario, Canada; ‡‡‡University of Calgary, Foothills Medical Centre, Calgary, Alberta, Canada; §§§Foothills Medical Centre, Calgary, Alberta, Canada; ‖‖‖Memorial University, St. Johns, Newfoundland, Canada; ¶¶¶The Ottawa Hospital, Ottawa, Ontario, Canada; ###Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; ****The Vancouver General Hospital and The University of British Columbia, Vancouver, British

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000283DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165479PMC
October 2014

Cost-effectiveness of rituximab in follicular lymphoma.

Expert Rev Pharmacoecon Outcomes Res 2012 Oct 11;12(5):569-77. Epub 2012 Nov 11.

Canadian Centre for Applied Research in Cancer Control, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/erp.12.57DOI Listing
October 2012